wearlinq
Wearable wireless cardiac monitors for real-time EKG analysis.
Company facts
- Founded
- 2019
- Employees
- 50
- Headquarters
- United States
- CEO
- Konrad Morzkowski
- Type
- Private
- Funding
- Series A · $14M · 2025
- Subsidiaries
- AMI Cardiac Monitoring, Wearlinq Labs
About
Our customers face the critical challenge of detecting and managing heart rhythm disorders, which is why we developed the eWave, the world's first 6-lead wireless cardiac monitor. Traditional monitoring solutions often rely on single-lead patches that can miss complex arrhythmias or require bulky, wired devices that disrupt patients' daily lives. We recognized that cardiologists need high-fidelity, multi-dimensional data to make accurate diagnoses, while patients deserve a comfortable, unobtrusive experience. To solve this, we created a vertically integrated ecosystem that combines our FDA-cleared eWave device with a user-friendly mobile app and a cloud-based AI platform. Our solution allows for continuous, long-term monitoring with a device that is remarkably light, discreet, and capable of running for five days on a single charge. By providing near real-time data analysis and delivering reports in under 48 hours, we empower healthcare providers to make faster, more informed clinical decisions. Our mission is to elevate the standard of cardiac care by ensuring that every heartbeat is captured with clarity and precision, ultimately improving patient outcomes and saving lives.
Open positions
IT Helpdesk - Support Technician (Entry Level)
Wearlinq is reimagining ambulatory cardiac monitoring with the first FDA-cleared, real-time, six-lead EKG designed to be easier for patients, clinicians, and health systems alike. We sit at the intersection of clinical…